Fate Therapeutics Inc (FATE)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Redmile Group

Jeremy Green

12,957,222 $1,124,557 16.64%
2.
ARK Investment Management

Catherine D. Wood

7,483,102 $649,458 +15% 1.2%
3.
Casdin Capital

Eli Casdin

3,400,000 $295,086 7.49%
4.
Farallon Capital

Thomas Steyer

1,905,000 $165,335 +1% 0.73%
5.
Lone Pine Capital

Stephen Mandel

1,749,284 $151,820 0.47%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$85.50 327,485 Large Shareholder, Director 12,957,222 2021-01-08 Filing
$28.31 1,412,928 Large Shareholder, Director 12,629,737 2020-06-11 Filing
$17.50 857,143 Large Shareholder, Director 11,216,809 2019-09-16 Filing
$13.50 3,703,704 Large Shareholder, Director 10,359,666 2018-09-25 Filing
$2.66 37,593 Officer 37,593 2016-11-23 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$67.46 800 Officer 95,740 2021-09-13 Filing
$66.84 8,391 Officer 96,540 2021-09-13 Filing
$65.94 15,809 Officer 104,931 2021-09-13 Filing
$88.01 20,000 Officer, Director 393,793 2021-08-19 Filing
$90.00 63 Officer 54,539 2021-08-19 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 343,567 $29,818,181 0.01%
2. 12,626 $1,095,811 0%
3. 7,570,681 $657,060 0.01%
4. 6,595,960 $572,464 0.01%
5. 6,450,927 $559,876 0.04%
News See All